GlobeImmune to delist

GlobeImmune Inc. (Nasdaq: GBIM) will delist from Nasdaq. Shares of the biopharmaceutical plummeted 77 cents to close at $1.02.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.